News
After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Goldman Sachs analyst Adam ...
Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
NEW YORK (AP) — Carlos Rodón pitched six innings of two-hit ball for his fifth straight win, Aaron Judge went 0 for 3 to fall under .400 for the first time in more than a month and the surging ...
But who are the panellists for this week? Blankety Blank will be back with a brand new episode tonight and there are plenty of famous faces set to appear. The revived show continues to go from ...
Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...
The NHL playoffs West Finals between the Edmonton Oilers and the Dallas Stars continue tonight, with Dallas leading the series 1-0 after a dominant 6-3 victory in Game 1. Face off is on Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results